Natco Pharma raises stake in South Africa’s Adcock Ingram to 49%
Indian pharmaceutical manufacturer Natco Pharma has increased its ownership interest in the South African firm Adcock Ingram to 49 percent. This strategic move strengthens the company's presence in the African healthcare market through its existing joint venture.
Natco Pharma Limited has announced it has successfully raised its stake in its South African joint venture entity, Natco Pharma (South Africa) Pty Ltd, which is partnered with Adcock Ingram. The transaction results in Natco Pharma holding a 49 percent equity interest in the venture.
The Hyderabad-based drugmaker initially established the collaboration as part of its long-term strategy to expand its international footprint and optimize its distribution network in the sub-Saharan region. This latest acquisition of shares highlights the company's commitment to the South African pharmaceutical sector.
Adcock Ingram remains a prominent player in the regional market, providing a platform for the introduction of various generic pharmaceutical products. The increased stake is expected to facilitate smoother operational integration and potential portfolio expansion for the partnership. Source: Corporate Filing
